Schwarzentraub Barbara J's Form 4 filing
CONMED CorpCNMD · filed May 10, 2024
- Accession no.
- 0001127602-24-015030
- Filed
- May 10, 2024
- Trade date
- May 8, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $99.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwarzentraub Barbara JCIK 0001788466 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2024 | Common Stock | PPurchaseAcquired | +1,442 | $69.26F1 | +$99,872.92 | 1,442 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $69.13 to $69.45. Full information regarding the number of shares purchased at each separate price will be provided upon request of the Commission staff, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.